Independent
Tenure on this board
12.1 yrs
Also a director at
Pennant Group Inc (PNTG)
Meeting calendar
ENSG · Annual meeting · Wednesday, May 13, 2026
Ensign Group Inc
4 nominees · 3 ballot items.
Election of four directors; ratification of Deloitte & Touche LLP as independent auditor; advisory (non-binding) approval of named executive officer compensation.
Market cap
$10.1B
1Y TSR
+13.2%
Board grade
B
Record date
Mar 18, 2026
Filing
DEF 14A
Meeting concluded · May 13, 2026
Follow how the vote landed and what changed on Ensign Group Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElection of four nominees (Barry M. Smith, Swati B. Abbott, Suzanne D. Snapper, Marivic Uychiat Pison) to the Board for specified terms.
- 2
Ratification of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026.
- 3
Advisory Vote on Named Executive Officer Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve executive compensation disclosed in the proxy statement.
Director elections
Nominees on the ballot4
Independent
Tenure on this board
6.5 yrs
Also a director at
Talkspace Inc (TALK)
Not independent
Tenure on this board
4.5 yrs
Also a director at
Pennant Group Inc (PNTG)
Not independent
Tenure on this board
0.9 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 7.6% | 4,439,360 | $895M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.3% | 3,120,298 | $629M |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 2,592,905 | $522M |
| 4 | BAILLIE GIFFORD CO | 4.0% | 2,319,358 | $467M |
| 5 | STATE STREET CORP | 3.5% | 2,062,850 | $416M |
| 6 | WASATCH ADVISORS LP | 3.5% | 2,057,995 | $415M |
| 7 | BlackRock, Inc. | 3.4% | 1,966,255 | $396M |
| 8 | FMR LLC | 3.2% | 1,850,473 | $373M |
| 9 | BAILLIE GIFFORD CO | 2.6% | 1,498,573 | $302M |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 1,424,209 | $287M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Ensign Group Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Apogee Therapeutics IncAPGE
Special meeting·Aug 11, 2026·$10.1B
Amneal Pharmaceuticals IncAMRX
Special meeting·Jul 31, 2026·$5.8B
Jazz Pharmaceuticals PLCJAZZ
Annual meeting·Jul 23, 2026·$15.2B
Doximity IncDOCS
Annual meeting·Aug 27, 2026·$4.1B
Haemonetics CorpHAE
Annual meeting·Jul 24, 2026·$3.6B
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.5B
Reference
Frequently asked questions
- When is the Ensign Group Inc 2026 annual meeting?
- Ensign Group Inc (ENSG) holds its 2026 annual shareholder meeting on Wednesday, May 13, 2026.
- What is the record date for the Ensign Group Inc 2026 meeting?
- The record date for the Ensign Group Inc 2026 meeting is Wednesday, March 18, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Ensign Group Inc's 2026 meeting?
- The board is presenting 4 director nominees at the Ensign Group Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Ensign Group Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Ensign Group Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.